Cargando…
Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD) worldwide. DN typically manifests by glomerular hyperfiltration and microalbuminuria; then, the disease progresses to impaired glomerular filtration rate, which leads to ESRD. Treatment options for DN include the strict...
Autores principales: | Dande, Ranadheer R., Peev, Vasil, Altintas, Mehmet M., Reiser, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449757/ https://www.ncbi.nlm.nih.gov/pubmed/28596971 http://dx.doi.org/10.1155/2017/3232848 |
Ejemplares similares
-
Diabetes Mellitus in the Transplanted Kidney
por: Peev, Vasil, et al.
Publicado: (2014) -
Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients
por: Morath, Christian, et al.
Publicado: (2022) -
Unwinding focal segmental glomerulosclerosis
por: Peev, Vasil, et al.
Publicado: (2017) -
Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High‐Sensitivity C‐Reactive Protein
por: Hayek, Salim S., et al.
Publicado: (2018) -
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022)